Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Published:2020-07 Issue:7 Volume:20 Page:827-838
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Koch Till,Dahlke Christine,Fathi Anahita,Kupke Alexandra,Krähling Verena,Okba Nisreen M A,Halwe Sandro,Rohde Cornelius,Eickmann Markus,Volz Asisa,Hesterkamp Thomas,Jambrecina Alen,Borregaard Saskia,Ly My L,Zinser Madeleine E,Bartels Etienne,Poetsch Joseph S H,Neumann Reza,Fux Robert,Schmiedel Stefan,Lohse Ansgar W,Haagmans Bart L,Sutter Gerd,Becker Stephan,Addo Marylyn M

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference27 articles.

1. A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation;Modjarrad;Nat Med,2016

2. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia;Zaki;N Engl J Med,2012

3. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities;Oboho;N Engl J Med,2015

4. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies;Song;J Virol,2013

5. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein;Widjaja;Emerg Microbes Infect,2019

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cold-adapted live attenuated MERS-CoV vaccine strain remains attenuated in mice after multiple passages in Vero cells at 37 °C;Archives of Microbiology;2024-09-06

2. Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans;Cell Reports;2024-08

3. Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach;iScience;2024-08

4. DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice;Virologica Sinica;2024-06

5. Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen;Human Vaccines & Immunotherapeutics;2024-05-17